Profiel
John Connelly worked as Vice President-Program & Alliance Management at Voyager Therapeutics, Inc. from 2015 to 2018.
He also worked as Chief Development Officer at Akouos, Inc. Mr. Connelly holds an MBA from Suffolk University and an undergraduate degree from the University of Vermont.
Eerdere bekende functies van John Connelly
Bedrijven | Functie | Einde |
---|---|---|
VOYAGER THERAPEUTICS, INC. | Corporate Officer/Principal | 01-02-2018 |
AKOUOS | Corporate Officer/Principal | - |
Opleiding van John Connelly
Suffolk University | Masters Business Admin |
University of Vermont | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
VOYAGER THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Akouos, Inc.
Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |